Category: Research

As an initiative of the Canadian Rheumatology Association and endorsed by Lupus Canada and the Canadian Network of Improved Outcomes in SLE, the Canadian SLE Working Group has recently published new recommendations for the assessment and monitoring of lupus patients in Canada. This working group

Health Canada’s recent approval of BENLYSTA™ marks the first new treatment available in almost 50 years to the over 1:1000 Canadian men, women and children who are living with Systemic Lupus Erythematosus (SLE) an autoimmune disease with no known cause or cure. Lupus most often